← Leaderboards
Ryan M Zurakowski
University Of Delaware
$1,115,840
Attributed
$1,408,809
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $237.3K · FY2009–22$250K$187.5K$125K$62.5K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,408,809 · 4
By mechanism
R21$1,253,505 · 3
R03$155,304 · 1
Top collaborators
- Jason Paul Gleghorn2 shared
- Elias Rosen2 shared
Most similar at University Of Delaware
Same institution · by research overlap
- Eric B Kmiec$3,863,760
- Hilary L Surratt$5,899,266
- Jason Paul Gleghorn$5,297,787
Others in their field
Top investigators on “Future”
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$274,284,003
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$246,289,043
Research focus
FuturePredictive ModelingClinical TrialsVirusSiteCellsSamplingPlasmaSchedulePharmaceutical PreparationsBloodAntiviral AgentsPatternRegimenMinimally InvasiveMediatingMathematical ModelInterruptionLymphoidMeasurementExperimental DesignsEvolutionAntiviral TherapyExhibits
Grant awards (8)
Cell-Mediated Antiretroviral Drug Transport in the Lymph Node$202,196
R21 · FY2022 · AI
Cell-Mediated Antiretroviral Drug Transport in the Lymph Node$237,258
R21 · FY2021 · AI
Evidence of cryptic replication in dolutegravir intensification data$77,652
R03 · FY2019 · AI · contact PI
Evidence of cryptic replication in dolutegravir intensification data$77,652
R03 · FY2018 · AI · contact PI
HIV 2-LTR Dynamics and Cryptic Viremia$203,185
R21 · FY2015 · AI · contact PI
HIV 2-LTR Dynamics and Cryptic Viremia$214,798
R21 · FY2014 · AI · contact PI
Analysis of Differential Resistance Emergence Risk for Differential Treatment App$191,250
R21 · FY2010 · AI · contact PI
Analysis of Differential Resistance Emergence Risk for Differential Treatment App$204,818
R21 · FY2009 · AI · contact PI